AAPA Members, login to view FREE Full Text for all articles. Not a member? Join today!

Institutional members access full text with Ovid®

Share this article on:

GnRH receptor antagonists for prostate cancer

Patrick, Emily; Whitson, Melissa; Smith, Amy; Parnell, Jamin; Thomas, Suzanne E. PhD; Blankenship, Clint C. PharmD, PA-C

Journal of the American Academy of Physician Assistants: July 2013 - Volume 26 - Issue 7 - p 51–52
doi: 10.1097/01.JAA.0000431511.13196.28
What's New in Oncology

ABSTRACT GnRH receptor antagonists can reduce testosterone levels without the adverse reactions caused by other drugs used to treat prostate cancer. These drugs also offer hope for prolonged control of metastasis.

Emily Patrick, Melissa Whitson, Amy Smith, and Jamin Parnell are students in the PA program at the Medical University of South Carolina in Charleston. Suzanne Thomas is a professor of research methods at the Medical University of South Carolina. Clint Blankenship is an assistant professor and academic coordinator of the PA program at the Medical University of South Carolina. The authors have indicated no relationships to disclose relating to the content of this article.

Mark E. Archambault, DHSc, PA-C, department editor

© 2013 American Academy of Physician Assistants.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website